You are required to be logged in to access the full website
User Name: Password:
Click here if you have forgotten your username or password
  • Home
  • Latest News
  • Search
  • About M2 Pharma
  • Subscribe
Business & Finance
Generics
Therapy Areas
Policy & Regulation
Research & Development
People
Business & Finance
Medifast announces quarterly cash dividend
11 December 2020 -

It was reported on Thursday that Medifast Inc (NYSE: MED), a United States-based nutrition and weight loss company, has announced a quarterly cash dividend for stockholders.

The company has declared a cash dividend of USD1.13 per share.

The dividend will be paid to shareholders of record as at 22 December 2020, on 5 February 2021.

Login
Username:

Password:


Related Headlines

Selvita acquires Fidelta

Eli Lilly increases quarterly dividend

Pfizer's board approves higher dividend for Q1 2021

Medifast announces quarterly cash dividend

Medivir and TetraLogic renegotiate birinapant agreement

China Accepts Emapalumab Marketing Authorization Application for Review

Abris to acquire 100% of Scanmed shares

Horizon Therapeutics, Halozyme Therapeutics Enter Global Collaboration and License Agreement for Enhanze Technology

Quest Diagnostics announces quarterly cash dividend

Pfizer negotiating with Brazil to supply its COVID-19 vaccine by early 2021

MEI Pharma reports financial results for Q3 ended 30 September 2020

Regenxbio reports quarter ended 30 September 2020 financial results

TFF Pharmaceuticals, Augmenta Bioworks Enter Into a Worldwide Joint Development Agreement for COVID-19 Monoclonal Antibody Therapies

Russia's Pharmasyntez seeks permission to produce COVID-19 drug without patent

US FDA Approves Kala Pharmaceuticals' Eysuvis for the Short-Term Treatment of the Signs and Symptoms of Dry Eye Disease

Home | Business & Finance | Generics | Therapy Areas | Policy & Regulation | Research & Development | People | Search | About M2 Pharma | Subscribe
Copyright © 2021